Livforsakringsbolaget Skandia, Omsesidigt Edwards Lifesciences Corp Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

$1.72 Billion
Q3 2024

A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 24,837 shares of EW stock, worth $1.84 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

24,837

Previous 16,837 47.51%

Holding current value

$1.84 Million

Previous $1.56 Million 5.34%

% of portfolio

0.09%

Previous 0.13%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$59.7 - $93.78 $477,600 - $750,240	8,000 Added 47.51%	24,837 $1.64 Million
Q2 2024 Jul 15, 2024	SELL	$84.3 - $94.31 $33,720 - $37,724	-400 Reduced 2.32%	16,837 $1.56 Million
Q4 2023 Jan 31, 2024	BUY	$61.71 - $77.76 $604,572 - $761,814	9,797 Added 131.68%	17,237 $1.31 Million
Q3 2023 Oct 20, 2023	BUY	$69.28 - $93.38 $200,912 - $270,802	2,900 Added 63.88%	7,440 $515,000
Q2 2023 Jul 06, 2023	BUY	$81.41 - $94.33 $293,076 - $339,588	3,600 Added 382.98%	4,540 $428,000
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $304,769 - $396,973	-3,700 Reduced 79.74%	940 $78,000
Q2 2022 Aug 16, 2022	SELL	$86.5 - $128.27 $155,700 - $230,886	-1,800 Reduced 27.95%	4,640 $441,000
Q1 2022 Jun 21, 2022	SELL	$101.96 - $128.34 $1.6 Million - $2.01 Million	-15,700 Reduced 70.91%	6,440 $758,000
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $967,967 - $1.19 Million	-9,100 Reduced 29.13%	22,140 $2.87 Million
Q3 2021 Oct 28, 2021	SELL	$102.91 - $122.75 $205,820 - $245,500	-2,000 Reduced 6.02%	31,240 $3.54 Million
Q2 2021 Jul 13, 2021	BUY	$83.84 - $104.76 $528,192 - $659,988	6,300 Added 23.39%	33,240 $3.44 Million
Q1 2021 May 07, 2021	BUY	$78.68 - $90.67 $157,360 - $181,340	2,000 Added 8.02%	26,940 $2.25 Million
Q4 2020 Mar 02, 2021	BUY	$71.69 - $91.23 $136,211 - $173,337	1,900 Added 8.25%	24,940 $2.28 Million
Q3 2020 Nov 09, 2020	BUY	$67.19 - $87.44 $60,471 - $78,696	900 Added 4.07%	23,040 $1.84 Million
Q2 2020 Jul 08, 2020	BUY	$57.54 - $76.95 $849,290 - $1.14 Million	14,760 Added 200.0%	22,140 $1.53 Million
Q1 2020 Apr 22, 2020	BUY	$52.41 - $81.0 $31,445 - $48,600	600 Added 8.85%	7,380 $1.39 Million
Q4 2019 Jan 28, 2020	SELL	$71.7 - $82.09 $57,360 - $65,672	-800 Reduced 10.55%	6,780 $1.58 Million
Q2 2019 Jul 19, 2019	BUY	$55.74 - $64.41 $27,870 - $32,205	500 Added 7.06%	7,580 $1.4 Million
Q3 2018 Oct 26, 2018	SELL	$45.7 - $58.03 $132,530 - $168,287	-2,900 Reduced 29.06%	7,080 $1.23 Million
Q2 2018 Jul 10, 2018	BUY	$42.45 - $51.3 $25,470 - $30,780	600 Added 6.4%	9,980 $1.45 Million
Q4 2017 Jan 18, 2018	SELL	$33.79 - $39.39 $43,927 - $51,207	-1,300 Reduced 12.17%	9,380 $1.06 Million
Q3 2017 Oct 12, 2017	BUY	$36.29 - $38.83 $387,577 - $414,704	10,680	10,680 $1.17 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.

Account

Livforsakringsbolaget Skandia, Omsesidigt Edwards Lifesciences Corp Transaction History